Leap Therapeutics

-$0.01 (-0.72%) As of 4:13 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LPTX and other ETFs, options, and stocks.

About LPTX

Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. Its clinical stage programs are DKN-01, which is a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1 and TRX518, which is a monoclonal antibody targeting the glucocorticoid-induced tumor necrosis factor-related receptor, or GITR.

CEO
Doug E. Onsi
Employees
30
Headquarters
Cambridge, Massachusetts
Founded
2011

LPTX Key Statistics

Market Cap
103.67M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
254.08K
High Today
$1.40
Low Today
$1.35
Open Price
$1.38
Volume
150.40K
52 Week High
$3.24
52 Week Low
$1.33

LPTX Earnings

-$0.55
-$0.37
-$0.18
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure